243 related articles for article (PubMed ID: 33718208)
1. Transcriptomic Profiling of
Laskaratos FM; Levi A; Schwach G; Pfragner R; Hall A; Xia D; von Stempel C; Bretherton J; Thanapirom K; Alexander S; Ogunbiyi O; Watkins J; Luong TV; Toumpanakis C; Mandair D; Caplin M; Rombouts K
Front Oncol; 2021; 11():629665. PubMed ID: 33718208
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
[TBL] [Abstract][Full Text] [Related]
3. Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cells.
Graf SD; Keber CU; Hattesohl A; Teply-Szymanski J; Hattesohl S; Guder M; Gercke N; Di Fazio P; Slater EP; Jesinghaus M; Denkert C; Bartsch DK; Lehman B
J Neuroendocrinol; 2024 Feb; 36(2):e13364. PubMed ID: 38246597
[TBL] [Abstract][Full Text] [Related]
4. Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; van Koestveld PM; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
Endocr Connect; 2022 Apr; 11(4):. PubMed ID: 35275095
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment.
Svejda B; Kidd M; Giovinazzo F; Eltawil K; Gustafsson BI; Pfragner R; Modlin IM
Cancer; 2010 Jun; 116(12):2902-12. PubMed ID: 20564397
[TBL] [Abstract][Full Text] [Related]
8. Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
[TBL] [Abstract][Full Text] [Related]
9. CTGF, intestinal stellate cells and carcinoid fibrogenesis.
Kidd M; Modlin I; Shapiro M; Camp R; Mane S; Usinger W; Murren J
World J Gastroenterol; 2007 Oct; 13(39):5208-16. PubMed ID: 17876891
[TBL] [Abstract][Full Text] [Related]
10. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
11. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
12. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
[TBL] [Abstract][Full Text] [Related]
13. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
Ratnayake GM; Laskaratos FM; Mandair D; Caplin ME; Rombouts K; Toumpanakis C
Curr Oncol Rep; 2022 Oct; 24(10):1281-1286. PubMed ID: 35554845
[TBL] [Abstract][Full Text] [Related]
14. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
15. PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.
Barazeghi E; Hellman P; Westin G; Stålberg P
Endocr Connect; 2019 Aug; 8(8):1126-1135. PubMed ID: 31349215
[TBL] [Abstract][Full Text] [Related]
16. Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
Drozdov I; Svejda B; Gustafsson BI; Mane S; Pfragner R; Kidd M; Modlin IM
PLoS One; 2011; 6(8):e22457. PubMed ID: 21853033
[TBL] [Abstract][Full Text] [Related]
17. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
[TBL] [Abstract][Full Text] [Related]
18. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis.
Wang Q; Yu C
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505
[TBL] [Abstract][Full Text] [Related]
20. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
